Among these, anti-phosphatidylserine/prothrombin antibodies (aPS/PT), aβ2GPI Domain I, IgA of aβ2GPI and aCL were highly specific for the identification of APS patients and have been the subject of previous investigations (9, 13–17). The gene discussed is ACLY; the disease is autoimmune polyendocrinopathy.